参考文献/References:
[1] Ballard LC,Cois A,Kea B. Peripartum cardiomyopathy:a review [J]. Curr Emerg Hosp Med Rep,2019,7(3):127-134.
[2] Chinweuba GC,Rutkofsky IH. Unveiling the mystery of peripartum cardiomyopathy:a traditional review[J]. Cureus,2020,12(10):112-117.
[3] Iorgoveanu C,Zaghloul A,Ashwath M. Peripartum cardiomyopathy:a review[J]. Heart Fail Rev,2021,26(6):1287-1296.
[4] 车千秋,王琼英,梁宇博,等. 围产期心肌病危险因素研究进展[J]. 临床心血管病杂志,2019,35 (11):18-21.
[5] Port Z,Ammari Z,Babapoor-Farrokhran S,et al. Assessing the future risks of subsequent pregnancies in peripartum cardiomyopathy[J]. Heart Fail Rev,2021(171):1-6.
[6] Bauersachs J,K?nig T,Van D,et al. Pathophysiology,diagnosis and management of peripartum cardiomyopathy:a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy[J]. Eur J Heart Fail,2019,21(7):827.
[7] Azibani F,Pfeffer TJ,M Ricke-Hoch,et al. Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers[J]. ESC Heart Failure,2020,7(2):25-31.
[8] Ersboll AS,Johansen M,Damm P,et al. Peripartum cardiomyopathy in Denmark:a retrospective,population-based study of incidence,management and outcome[J]. Eur J Heart Fail,2017,19(12):1712-1720.
[9] Sliwa K,Mebazaa A,Hilfiker-Kleiner D, et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM)[J]. Eur J Heart Fail,2017,19(9):1131-1141.
[10] 车千秋,王琼英,梁宇博,等. 围产期心肌病的病因学研究进展[J]. 中华心力衰竭和心肌病杂志（中英文）,2019,3(1):41-44.
[11] Cowgill JA,Francis SA,Sawyer DB. Anthracycline and peripartum cardiomyopathies[J]. Circ Res,2019,124(11):1633-1646.
[12] Schaufelberger M. Cardiomyopathy and pregnancy[J]. Heart,2019,105(20):1543-1551.
[13] van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ,et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy[J]. Circulation,2010,121(20): 2169-2175.
[14] Davies JE,Winokur TS,Aaron MF,et al. Cardiomyopathy in a carrier of Duchenne’s muscular dystrophy[J]. J Heart Lung Transpl,2001,20(7):781-784.
[15] Cheng VE,Prior DL. Peripartum cardiomyopathy in a previously asymptomatic carrier of Duchenne muscular dystrophy[J]. Heart Lung Circ,2013,22(8):677-681.
[16] Ahmed A, Spinty S, Murday V,?et al. A de-novo deletion of dystrophin provoking severe ’peri-partum cardiomyopathy’:the importance of genetic testing in peripartum cardiomyopathy to uncover female carriers[J]. Int J Cardiol,2016,203:1084-1085.
[17] 曾艳,赵韶静,陈华茜,等. 溶酶体相关膜蛋白2及其抗体与慢性肾脏病患者肾功能变化的关系[J]. 中国医师进修杂志,2019,42(9):776-781.
[18] 王哲,林丽云,袁云,等. DMD基因5’端三个新剪切突变导致不同的疾病表型[J]. 中华医学遗传学杂志,2019,36(7):666-671.
[19] Morales A,Painter T,Li R,et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy[J]. Circulation,2010,121(20):2176-2182.
[20] Hao E,Zhang G,Mu L,et al. Establishment of a human MYH6 compound heterozygous knockout hESC line to model cardiomyopathy and congenital heart defects by CRISPR/Cas9 system[J]. Stem Cell Res,2021,50(2):102128.
[21] 郭家隆 ,白蕊,孙海瑞,等. 国人肥厚型心肌病基因型表型相关性的初步探索[J]. 中华胸心血管外科杂志,2018,34(6):370-375.
[22] 刘小平,何瑞霞,冯玉宝,等. 内蒙古自治区一家族性扩张型心肌病家系致病基因筛查[J]. 中华心血管病杂志,2019,47(3):197-203.
[23] Kolokotronis K,Kühnisch J,Klopocki E,et al. Biallelic mutation in MYH7 and MYBPC3 leads to severe cardiomyopathy with left ventricular noncompaction phenotype[J]. Hum Mutat,2019,40(3):124-129.
[24] Pea ML,Ochoa JP,Barriales VR,et al. Prognostic implications of pathogenic truncating variants in the TTN gene[J]. Int J Cardiol,2020,316(1):180-183.
[25] Herman DS,Lam L,Taylor MRG,et al. Truncations of titin causing dilated cardiomyopathy[J]. N Engl J Med,2012,366(7):619-628.
[26] van Spaendonck-Zwarts KY,Posafalvi A,van den Berg MP,et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy[J]. Eur Heart J,2014,35(32):2165-2173.
[27] Biteker M.Shared genetic predisposition in peripartum and dilated cardiomyopathies[J]. N Engl J Med,2016,374(26):233-241.
[28] 王玮,周明礼.达比加群酯抗凝治疗与基因多态性研究进展[J].心血管病学进展,2018,39(3):494-497.
[29] Horne BD,Rasmusson KD,Alharethi R,et al. Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy[J]. Circ Cardiovasc Genet,2011,4(4):359-366.
[30] Sheppard R,Hsich E,Damp J,et al. GNB3 C825T polymorphism and myocardial recovery in peripartum cardiomyopathy: results of the multicenter investigations of pregnancy-associated cardiomyopathy study[J]. Circ Heart Fail,2016,9(3):e002683.
[31] 向都.热休克蛋白保护缺血再灌注损伤的研究进展[J].疑难病杂志,2019,18(4):428-432.
[32] Liu GS,Gardner G,Adly G,et al. A novel human S10F-Hsp20 mutation induces lethal peripartum cardiomyopathy[J]. J Cell Mol Med,2018,22(8):3911-3919.
[33] Shatov VM,Gusev NB.Physico-chemical properties of two point mutants of small heat shock protein HspB6 (Hsp20) with abrogated cardioprotection[J]. Biochimie,2020,174:126-135.
[34] Liu GS,Zhu HY,Cai WF,et al. Regulation of BECN1-mediated autophagy by HSPB6:insights from a human HSPB6 mutant[J].Autophagy,2018,14(1):80-97.